Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperfractionation: where do we stand?

H P Beck-Bornholdt1, H H Dubben, C Liertz-Petersen

  • 1Institute of Biophysics and Radiobiology, University of Hamburg, Germany.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

[Old wine in new bottles? The study of Hugosson et al on PSA-based screening].

Der Urologe. Ausg. A·2011
Same author

Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.

British journal of cancer·2010
Same author

[PSA-screening: sensible or meaningless?].

Der Urologe. Ausg. A·2009
Same author

Distinct mechanisms of nonhomologous end joining in the repair of site-directed chromosomal breaks with noncomplementary and complementary ends.

Radiation research·2006
Same author

Monitoring of biological odour filtration in closed environments with olfactometry and an electronic nose.

Water science and technology : a journal of the International Association on Water Pollution Research·2004

Hyperfractionated radiotherapy aims to increase tumor control by escalating doses without worsening late complications. However, clinical evidence, particularly for head and neck cancer, remains inconsistent, suggesting standard radiation doses per fraction are often optimal.

Area of Science:

  • Radiation oncology
  • Clinical oncology
  • Cancer treatment

Background:

  • Hyperfractionation in radiotherapy is theorized to improve therapeutic gain.
  • This involves delivering smaller radiation doses more frequently.
  • The goal is to increase tumor control while minimizing late toxicity.

Purpose of the Study:

  • To review empirical evidence supporting therapeutic gain from hyperfractionated radiotherapy.
  • To evaluate the effectiveness of hyperfractionation in clinical practice.
  • To determine if hyperfractionation offers advantages over standard radiotherapy fractionation.

Main Methods:

  • Systematic review of clinical data on hyperfractionated radiotherapy.
  • Analysis of outcomes, focusing on tumor control and late complications.

Related Experiment Videos

  • Specific attention to studies involving head and neck cancer.

    • Main Results:

    • Extensive clinical data exist, particularly for head and neck cancers.
    • The evidence supporting therapeutic gain from hyperfractionation is inconsistent.
    • Current findings suggest that standard doses per fraction are often well-chosen.

    Conclusions:

    • Hyperfractionation does not consistently demonstrate improved tumor control or reduced late complications.
    • The expected therapeutic gain from hyperfractionation is not consistently supported by clinical evidence.
    • Standard radiotherapy fractionation appears to be an effective choice for many clinical scenarios.